Zanzalintinib (XL092)

Name: Zanzalintinib (XL092) in Metastatic colorectal cancer: Definition and etiology
Published: 2026-09-14T15:39:06-04:00

Metastatic colorectal cancer

Manufacturer: Exelixis
Regulatory submission: NDA submitted December 2025
Launch: Not announced
Last updated: September 19, 2026

Section

Product information and disease description Place of product in therapy Disease description

Definition and etiology

2 evidence topics · 2 sources

Definition of colorectal cancer

“Colorectal cancer is a disease that happens when cells in the colon or rectum grow out of control.” (opens the source at this quote in a new tab)

Risk factors

“Your risk of getting colorectal cancer increases as you get older.” (opens the source at this quote in a new tab)
“A personal or family history of colorectal cancer or colorectal polyps.” (opens the source at this quote in a new tab)